Neurogene Inc (NASDAQ: NGNE) kicked off on Monday, down -42.58% from the previous trading day, before settling in for the closing price of $34.51. Over the past 52 weeks, NGNE has traded in a range of $12.49-$74.49.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -20.00%. While this was happening, its average annual earnings per share was recorded -251.58%. With a float of $10.11 million, this company’s outstanding shares have now reached $12.82 million.
Let’s determine the extent of company efficiency that accounts for 91 employees. In terms of profitability, gross margin is -1937.3%, operating margin of -8756.32%, and the pretax margin is -5993.62%.
Neurogene Inc (NGNE) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Neurogene Inc is 22.21%, while institutional ownership is 95.60%.
Neurogene Inc (NGNE) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -251.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.10% during the next five years compared to -16.09% drop over the previous five years of trading.
Neurogene Inc (NASDAQ: NGNE) Trading Performance Indicators
Take a look at Neurogene Inc’s (NGNE) current performance indicators. Last quarter, stock had a quick ratio of 12.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 243.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.71, a number that is poised to hit -1.19 in the next quarter and is forecasted to reach -4.68 in one year’s time.
Technical Analysis of Neurogene Inc (NGNE)
Looking closely at Neurogene Inc (NASDAQ: NGNE), its last 5-days average volume was 1.13 million, which is a jump from its year-to-date volume of 0.15 million. As of the previous 9 days, the stock’s Stochastic %D was 7.09%. Additionally, its Average True Range was 7.43.
During the past 100 days, Neurogene Inc’s (NGNE) raw stochastic average was set at 1.58%, which indicates a significant increase from 1.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 367.05% in the past 14 days, which was higher than the 156.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $46.80, while its 200-day Moving Average is $39.05. However, in the short run, Neurogene Inc’s stock first resistance to watch stands at $22.76. Second resistance stands at $25.70. The third major resistance level sits at $27.61. If the price goes on to break the first support level at $17.91, it is likely to go to the next support level at $16.00. Should the price break the second support level, the third support level stands at $13.06.
Neurogene Inc (NASDAQ: NGNE) Key Stats
The company with the Market Capitalisation of 226.75 million has total of 12,994K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -36,320 K annual income. Company’s last quarter sales were recorded 930 K and last quarter income was -18,490 K.
